Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation

OBJECTIVE: To determine the effectiveness of erenumab in treating headaches in idiopathic intracranial hypertension (IIH) in whom papilledema had resolved. BACKGROUND: Disability in IIH is predominantly driven by debilitating headaches with no evidence for the use of preventative therapies. Headache...

Descripción completa

Detalles Bibliográficos
Autores principales: Yiangou, Andreas, Mitchell, James L., Fisher, Claire, Edwards, Julie, Vijay, Vivek, Alimajstorovic, Zerin, Grech, Olivia, Lavery, Gareth G., Mollan, Susan P., Sinclair, Alexandra J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898289/
https://www.ncbi.nlm.nih.gov/pubmed/33316102
http://dx.doi.org/10.1111/head.14026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898289/
https://www.ncbi.nlm.nih.gov/pubmed/33316102
http://dx.doi.org/10.1111/head.14026

Ejemplares similares